PENG Block With or Without PPD Block for Postoperative Analgesia After Total Hip Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKirsehir Ahi Evran Universitesi

About this trial

This single-center, prospective, randomized controlled clinical trial aims to compare the postoperative analgesic efficacy of PENG block with or without posterior pericapsular deep gluteal block in adult patients undergoing elective primary total hip arthroplasty under spinal anesthesia. Total hip arthroplasty is commonly associated with moderate to severe postoperative pain. Although PENG block provides analgesia for the anterior hip capsule, some patients may still experience pain originating from the posterior capsule. The addition of PPD block may improve analgesia by targeting posterior articular branches. Participants will be randomized into two groups: one group will receive PENG block, and the other group will receive PENG plus PPD block. Postoperative pain will be assessed using the Numeric Rating Scale (NRS). The study will compare postoperative pain scores and other analgesia-related outcomes between groups.

Eligibility criteria

Qualifiers

Adults aged 18 years and older

American Society of Anesthesiologists (ASA) physical status I-III

Scheduled for elective primary total hip arthroplasty under spinal anesthesia

Able to provide written informed consent

Disqualifiers

ASA physical status IV or V

Serious concomitant cardiac, respiratory, hepatic, or renal disease

Known neuropsychiatric disorder

Cognitive impairment preventing understanding or response to the Numeric Rating Scale (NRS)

Trial design

Treatments tested in this trial

  • PENG Block
  • Deep posterior gluteal compartment block

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations